Alder BioPharmaceuticals: 2Q Earnings Snapshot
BOTHELL, Wash. (AP) _ Alder BioPharmaceuticals Inc. (ALDR) on Tuesday reported a loss of $68.4 million in its second quarter.
On a per-share basis, the Bothell, Washington-based company said it had a loss of $1.04.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.14 per share.
Alder BioPharmaceuticals shares have climbed 69 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $19.40, more than doubling in the last 12 months.